Spine device study pulled before it began

NCT ID NCT05944081

Terminated Knowledge-focused Sponsor: Aesculap AG Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study was designed to check how well the Arcadius XP L spine fusion device works and if it is safe for people with chronic low-back pain from conditions like degenerative disc disease or instability. The plan was to follow 60 patients for at least one year after surgery. However, the study was withdrawn before any patients were enrolled, so no new data was collected.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Arcadius XP L interbody fusion device

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC LOW-BACK PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

intervertebral disk degenerative disorder lumbar disk degenerative disorder spondylolisthesis spondylolysis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC LOW-BACK PAIN DEGENERATIVE DISC DISEASE POSTDISCECTOMY SYNDROME POSTTRAUMATIC INSTABILITY SPONDYLOLYSIS LUMBAR

Contacts and locations

Locations

Medius Klinik Nürtingen

Nürtingen, Baden-Wurttemberg, 72622, Germany
Rems-Murr-Klinik Schorndorf

Schorndorf, Baden-Wurttemberg, 73614, Germany
Schelztor-Klinik Esslingen

Esslingen am Neckar, Baden-Wurttemberg, 73728, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.